Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kalpna Durairaj

Otolaryngology Sun Valley, CA Medical Doctor

NPI 1366488603 CMS profile 334340

9375 San Fernando Rd, Sun Valley, CA 91352

Open in the dashboard

General payments

$348,184

783 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kalpna Durairaj of Sun Valley, CA is reported in the CMS Open Payments database as having received $348,184 across 783 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Otolaryngology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $44,138 58
2024 General $69,129 85
2023 General $8,803 64
2022 General $106,035 147
2021 General $59,481 146
2020 General $18,746 75
2019 General $41,852 208

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kalpna Durairaj
  • Otolaryngology median
  • Middle half of Otolaryngology
  • National median

In program year 2025, general payments to Kalpna Durairaj were reported at $44,138. Among 6,588 Otolaryngology profiles paid that year, the median was $317 and the middle half received between $125 and $815.

Show as a table
Year Kalpna Durairaj Otolaryngology median Middle half National median
2019 $41,852 $194 $82–$512 $163
2020 $18,746 $118 $42–$280 $114
2021 $59,481 $167 $63–$444 $132
2022 $106,035 $216 $84–$545 $149
2023 $8,803 $235 $93–$588 $160
2024 $69,129 $280 $111–$699 $164
2025 $44,138 $317 $125–$815 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Galderma Laboratories, L.P. $178,024 255 payments
  2. Merz North America, Inc. $167,929 453 payments
  3. AbbVie, Inc. $939 28 payments
  4. Allergan Inc. $661 28 payments
  5. CSL Behring $297 6 payments
  6. Musculoskeletal Transplant Foundation Inc. $126 6 payments
  7. Bioventus LLC $94 2 payments
  8. OptiNose US, Inc. $42 2 payments
  9. Stryker Corporation $33 1 payment
  10. Regeneron Healthcare Solutions, Inc. $20 1 payment
  11. Other $18 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $138,120 33 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $125,803 34 payments
  3. Travel and Lodging $47,947 78 payments
  4. Food and Beverage $36,006 632 payments
  5. Education $308 6 payments
Products named General payments · program years 2019–2025
  1. Xeomin Dermatology $80,160 255 payments
  2. Xeomin musculoskeletal $2,721 33 payments
  3. BOTOX $947 25 payments
  4. ASCLERA $483 7 payments
  5. DYSPORT $447 8 payments
  6. Kcentra $297 6 payments
  7. DYSPORT $190 10 payments
  8. BOTOX COSMETIC $149 11 payments
  9. EXOGEN ULTRASOUND BONE HEALING SYSTEM $94 2 payments
  10. Xhance $42 2 payments
  11. Other $71 3 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

783 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Otolaryngology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record